ARCHIVES

Family History of BRCA Mutation Does Not Equal Increased Risk

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

Geography Still An Issue For Centers: Durant Asks Is It “Holy Water” or Money

April 26, 1985

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007

Blue Cross, Broder Skirmish On Coverage Of Group C Drugs

November 3, 1989

Michael Atkins Named Deputy Director at Georgetown Lombardi Cancer Center

March 2, 2012

Funding opportunities listed.

November 19, 2004